Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Mark J. Ratain and Harvey M. Golomb.

 
Connection Strength
 
 
 
0.954
 
  1. Ratain MJ, Vardiman JW, Barker CM, Golomb HM. Prognostic variables in hairy cell leukemia after splenectomy as initial therapy. Cancer. 1988 Dec 01; 62(11):2420-4.
    View in: PubMed
    Score: 0.102
  2. Golomb HM, Ratain MJ. Recent advances in the treatment of hairy-cell leukemia. N Engl J Med. 1987 Apr 02; 316(14):870-2.
    View in: PubMed
    Score: 0.091
  3. Ratain MJ, Vardiman JW, Golomb HM. The role of interferon in the treatment of hairy cell leukemia. Semin Oncol. 1986 Sep; 13(3 Suppl 2):21-8.
    View in: PubMed
    Score: 0.087
  4. Vokes EE, Ansari RH, Masters GA, Hoffman PC, Klepsch A, Ratain MJ, Sciortino DF, Lad TE, Krauss S, Fishkin PA, Golomb HM. A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer. Ann Oncol. 1998 Oct; 9(10):1085-90.
    View in: PubMed
    Score: 0.051
  5. Spielberger RT, Mick R, Ratain MJ, Golomb HM. Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986. Leuk Lymphoma. 1994; 14 Suppl 1:89-93.
    View in: PubMed
    Score: 0.036
  6. Golomb HM, Ratain MJ, Mick R, Daly K. Interferon treatment for hairy cell leukemia: an update on a cohort of 69 patients treated from 1983-1986. Leukemia. 1992 Nov; 6(11):1177-80.
    View in: PubMed
    Score: 0.034
  7. Golomb HM, Ratain MJ, Mick R, Daly K. The treatment of hairy cell leukemia: an update. Leukemia. 1992; 6 Suppl 2:24-7.
    View in: PubMed
    Score: 0.032
  8. Golomb HM, Fefer A, Golde DW, Ozer H, Portlock C, Silber R, Rappeport J, Ratain MJ, Thompson J, Bonnem E, Spiegel R, Tensen L, Burke JS, Vardiman JW. Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B. Leuk Lymphoma. 1991; 4(2):99-102.
    View in: PubMed
    Score: 0.030
  9. Golomb HM, Ratain MJ, Fefer A, Thompson J, Portlock CS, Ozer H, Mick R, Chiavello J, Israel RJ, Bonnem EM. Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients. Leuk Lymphoma. 1991; 5(5-6):335-40.
    View in: PubMed
    Score: 0.030
  10. Richards JM, Mick R, Latta JM, Daly K, Ratain MJ, Vardiman JW, Golomb HM. Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia. Blood. 1990 Nov 15; 76(10):1941-5.
    View in: PubMed
    Score: 0.029
  11. Mick R, Ratain MJ, Golomb HM. Duration of response after interferon treatment of hairy cell leukemia. Blood. 1990 Jun 15; 75(12):2465-7.
    View in: PubMed
    Score: 0.028
  12. Doane LL, Ratain MJ, Golomb HM. Hairy cell leukemia. Current management. Hematol Oncol Clin North Am. 1990 Apr; 4(2):489-502.
    View in: PubMed
    Score: 0.028
  13. Moormeier JA, Ratain MJ, Westbrook CA, Vardiman JW, Daly KM, Golomb HM. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Aug 02; 81(15):1172-4.
    View in: PubMed
    Score: 0.027
  14. Golomb HM, Ratain MJ, Moormeier J. What is the choice of treatment for hairy cell leukemia? J Clin Oncol. 1989 Feb; 7(2):156-8.
    View in: PubMed
    Score: 0.026
  15. Moormeier JA, Westbrook CA, Ratain MJ, Golomb HM. Interferon Alfa-2b Antibodies and Clinical Resistance in a Patient with Hairy Cell Leukemia. Leuk Lymphoma. 1989; 1(1):43-5.
    View in: PubMed
    Score: 0.026
  16. Ratain MJ, Golomb HM, Vardiman JW, Westbrook CA, Barker C, Hooberman A, Bitter MA, Daly K. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables. J Clin Oncol. 1988 Nov; 6(11):1714-21.
    View in: PubMed
    Score: 0.025
  17. Golomb HM, Fefer A, Golde DW, Ozer H, Portlock C, Silber R, Rappeport J, Ratain MJ, Thompson J, Bonnem E, et al. Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon-alfa2b. Semin Oncol. 1988 Oct; 15(5 Suppl 5):7-9.
    View in: PubMed
    Score: 0.025
  18. Vardiman JW, Gilewski TA, Ratain MJ, Bitter MA, Bradlow BA, Golomb HM. Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique. Am J Clin Pathol. 1988 Sep; 90(3):250-6.
    View in: PubMed
    Score: 0.025
  19. Lembersky BC, Ratain MJ, Golomb HM. Skeletal complications in hairy cell leukemia: diagnosis and therapy. J Clin Oncol. 1988 Aug; 6(8):1280-4.
    View in: PubMed
    Score: 0.025
  20. Golomb HM, Ratain MJ, Fefer A, Thompson J, Golde DW, Ozer H, Portlock C, Silber R, Rappeport J, Bonnem E, et al. Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia. J Natl Cancer Inst. 1988 May 04; 80(5):369-73.
    View in: PubMed
    Score: 0.025
  21. Lembersky BC, Ratain MJ, Westbrook C, Golomb HM. Rapid response to 2'-deoxycoformycin in advanced hairy cell leukemia after failure of interferons alpha and gamma. Am J Hematol. 1988 Jan; 27(1):60-2.
    View in: PubMed
    Score: 0.024
  22. Vokes EE, Bitter MA, Ratain MJ, Prystowsky MB, Daly K, Golomb HM. Flow cytometry in hairy cell leukemia before and during interferon alfa-2b therapy. Cancer. 1987 Jun 15; 59(12):1987-91.
    View in: PubMed
    Score: 0.023
  23. Golomb HM, Fefer A, Golde DW, Ozer H, Portlock C, Silber R, Rappeport J, Ratain MJ, Thompson J, Bonnem EM, et al. Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia. Semin Oncol. 1987 Jun; 14(2 Suppl 2):13-7.
    View in: PubMed
    Score: 0.023
  24. Ratain MJ, Golomb HM, Bardawil RG, Vardiman JW, Westbrook CA, Kaminer LS, Lembersky BC, Bitter MA, Daly K. Durability of responses to interferon alfa-2b in advanced hairy cell leukemia. Blood. 1987 Mar; 69(3):872-7.
    View in: PubMed
    Score: 0.023
  25. Golomb HM, Jacobs A, Fefer A, Ozer H, Thompson J, Portlock C, Ratain M, Golde D, Vardiman J, Burke JS, et al. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients. J Clin Oncol. 1986 Jun; 4(6):900-5.
    View in: PubMed
    Score: 0.021
  26. Golomb HM, Ratain MJ, Vardiman JW. Sequential treatment of hairy cell leukemia: a new role for interferon. Important Adv Oncol. 1986; 311-21.
    View in: PubMed
    Score: 0.021
  27. Ratain MJ, Golomb HM, Vardiman JW, Vokes EE, Jacobs RH, Daly K. Treatment of hairy cell leukemia with recombinant alpha 2 interferon. Blood. 1985 Mar; 65(3):644-8.
    View in: PubMed
    Score: 0.020
  28. Vokes EE, Ratain MJ, Janisch L, Hoffman PC, Golomb HM, Schilsky RL. A phase I study of cisplatin, 5-fluorouracil and leucovorin with escalating doses of hydroxyurea in chemotherapy naive patients. Eur J Cancer. 1991; 27(2):217-8.
    View in: PubMed
    Score: 0.007
  29. Bardawil RG, Ratain MJ, Golomb HM, Bitter MA, Groves C, Vardiman JW. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia. Leukemia. 1987 Apr; 1(4):340-3.
    View in: PubMed
    Score: 0.006
  30. Bardawil RG, Groves C, Ratain MJ, Golomb HM, Vardiman JW. Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemia. Am J Clin Pathol. 1986 Feb; 85(2):194-201.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.